tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NGM is currently covered by 7 analysts with an average price target of $5.18. This is a potential upside of $3.64 (236.36%) from yesterday's end of day stock price of $1.54.
NGM Biopharmaceuticals's activity chart (see below) currently has 53 price targets and 49 ratings on display. The stock rating distribution of NGM is 92.86% BUY and 7.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.8% with an average time for these price targets to be met of 158 days.
Highest price target for NGM is $3.5, Lowest price target is $1.55, average price target is $5.18.
Most recent stock forecast was given by RITU BARAL from TD COWEN on 28-Feb-2024. First documented stock forecast 29-Apr-2019.
Currently out of the existing stock ratings of NGM, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1.55
$0.01 (0.65%)
9
1 months 27 days ago
4/6 (66.67%)
$0.02 (1.31%)
233
Buy
3.5
$1.96 (127.27%)
7
5 months 2 days ago
3/9 (33.33%)
$2.79 (392.96%)
262
Buy
3.5
$1.96 (127.27%)
7
5 months 2 days ago
0/2 (0%)
$2.79 (392.96%)
Buy
6
$4.46 (289.61%)
4
1 years 5 months 20 days ago
1/8 (12.5%)
$0.64 (11.94%)
3
Buy
4
$2.46 (159.74%)
36
1 years 6 months 7 days ago
4/6 (66.67%)
$0.59 (17.30%)
187
What is NGM (NGM Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NGM (NGM Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most bullish on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most reserved on NGM (NGM Biopharmaceuticals)?
